| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9960209 | Journal of the American College of Cardiology | 2005 | 7 Pages | 
Abstract
												Treatment with alpha-tocopherol, vitamin C, and low doses of atorvastatin (20 mg once daily) did not affect the progression of coronary calcification. Treatment may have reduced ASCVD events, especially in subjects with calcium scores >400, but these effects did not achieve conventional levels of statistical significance.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Yadon (FACC), Louise A. (FACC), Marguerite RN, David DrPh, Alan D. (FACC), 
											